Page last updated: 2024-08-26

arsenic and phenylarsonous acid

arsenic has been researched along with phenylarsonous acid in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19901 (10.00)18.7374
1990's0 (0.00)18.2507
2000's2 (20.00)29.6817
2010's7 (70.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Knowles, FC1
Motomizu, S; Oshima, M; Oshita, K; Sabarudin, A; Takayanagi, T1
Allen, JD; Decollogne, S; Dilda, PJ; Haber, M; Hogg, PJ; Norris, MD; Weerakoon, L1
Camphausen, K; Chinen, L; Dilda, PJ; Don, AS; Dyszlewski, M; Hemenway, C; Hogg, PJ; Karwa, A; Kuan, KT; MacDonald, J; Massamiri, T; Naik, A; Park, D; Warner, B; Wong, JW1
Arroyo-Abad, U; Elizalde-González, MP; Mattusch, J; Matysik, FM; Möder, M1
Dick, LJ; Elliott, MA; Ford, SJ; Gray, A; Halbert, GW; Hogg, PJ; Hume, A; Parris, C; Ram, A1
Blackburn, AC; Dilda, PJ; Gang, BP; Hogg, PJ1
Chung, SA; Decollogne, S; Dilda, PJ; Hau, E; Hogg, PJ; Luk, PP; McDonald, KL; Shen, H1
Chung, SA; Decollogne, S; Dilda, PJ; Fedier, A; Heinzelmann-Schwarz, V; Hogg, PJ; Joshi, S; Luk, PP; Nixdorf, S; Yeo, RX1
Hogg, PJ; Lu, H; Noy, JM; Stenzel, M; Yang, JL1

Other Studies

10 other study(ies) available for arsenic and phenylarsonous acid

ArticleYear
Reactions of lipoamide dehydrogenase and glutathione reductase with arsonic acids and arsonous acids.
    Archives of biochemistry and biophysics, 1985, Volume: 242, Issue:1

    Topics: Arsanilic Acid; Arsenic; Arsenicals; Arsenites; Dihydrolipoamide Dehydrogenase; Flavin-Adenine Dinucleotide; Glutathione Reductase; Kinetics; Mathematics; NAD

1985
Adsorption behavior of uranium(VI) and other ionic species on cross-linked chitosan resins modified with chelating moieties.
    Talanta, 2009, Sep-15, Volume: 79, Issue:4

    Topics: Adsorption; Arsenicals; Catechols; Chelating Agents; Chitosan; Cross-Linking Reagents; Imino Acids; Lanthanoid Series Elements; Organophosphonates; Serine; Uranium

2009
Optimization of the antitumor efficacy of a synthetic mitochondrial toxin by increasing the residence time in the cytosol.
    Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20

    Topics: Animals; Antineoplastic Agents; Arsenicals; Biomimetics; Cattle; Cell Line, Tumor; Cell Proliferation; Cytosol; Dogs; Endothelial Cells; Extracellular Space; Female; Humans; Mice; Mitochondria; Oligopeptides; Pancreatic Neoplasms; Time Factors; Xenograft Model Antitumor Assays

2009
Noninvasive imaging of cell death using an Hsp90 ligand.
    Journal of the American Chemical Society, 2011, Mar-09, Volume: 133, Issue:9

    Topics: Animals; Arsenicals; Carbocyanines; Carcinoma, Lewis Lung; Cell Death; Colorectal Neoplasms; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Pentetic Acid; Peptides; Protein Binding; Radioisotopes

2011
Identification of degradation products of phenylarsonic acid and o-arsanilic acid in contact with suspensions of soils of volcanic origin.
    Talanta, 2012, Sep-15, Volume: 99

    Topics: Arsanilic Acid; Arsenicals; Soil; Suspensions; Volcanic Eruptions

2012
Elimination of the antimicrobial action of the organoarsenical cancer therapeutic, 4-(N-(S-glutathionylacetyl)amino) phenylarsonous acid, before finished product sterility testing.
    The Journal of pharmacy and pharmacology, 2013, Volume: 65, Issue:11

    Topics: Anti-Infective Agents; Antineoplastic Agents; Arsenicals; Chelating Agents; Infusions, Parenteral; Neoplasms; Staphylococcus aureus; Sulfhydryl Compounds

2013
Targeting of two aspects of metabolism in breast cancer treatment.
    Cancer biology & therapy, 2014, Volume: 15, Issue:11

    Topics: Apoptosis; Arsenicals; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Dichloroacetic Acid; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Inhibitory Concentration 50; Mitochondria; Molecular Targeted Therapy; Reactive Oxygen Species

2014
Dual-targeting of aberrant glucose metabolism in glioblastoma.
    Journal of experimental & clinical cancer research : CR, 2015, Feb-05, Volume: 34

    Topics: Arsenicals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Dichloroacetic Acid; G2 Phase Cell Cycle Checkpoints; Gene Expression; Glioblastoma; Glucose; Humans; Membrane Potential, Mitochondrial; Mitochondria; Multidrug Resistance-Associated Proteins; Oxidative Stress; Reactive Oxygen Species

2015
Alterations in the mitochondrial responses to PENAO as a mechanism of resistance in ovarian cancer cells.
    Gynecologic oncology, 2015, Volume: 138, Issue:2

    Topics: Animals; Arsenicals; Biomimetic Materials; Carcinoma, Ovarian Epithelial; Cell Line, Tumor; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Mitochondria; Molecular Targeted Therapy; Neoplasms, Glandular and Epithelial; Ovarian Neoplasms; Oxidative Stress; Xenograft Model Antitumor Assays

2015
Direct Polymerization of the Arsenic Drug PENAO to Obtain Nanoparticles with High Thiol-Reactivity and Anti-Cancer Efficiency.
    Bioconjugate chemistry, 2018, 02-21, Volume: 29, Issue:2

    Topics: Antineoplastic Agents; Arsenicals; Cell Line, Tumor; Cell Proliferation; Drug Carriers; Humans; Mitochondria; Nanoparticles; Osteosarcoma; Polymerization; Polymers; Sulfhydryl Compounds

2018